These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10418840)

  • 1. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up.
    On AY; Kirazli Y; Kismali B; Aksit R
    Am J Phys Med Rehabil; 1999; 78(4):344-9. PubMed ID: 10418840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial.
    Kirazli Y; On AY; Kismali B; Aksit R
    Am J Phys Med Rehabil; 1998; 77(6):510-5. PubMed ID: 9862538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of phenol with botulinus toxin type A for the treatment of spasticity.
    Kishner S
    Am J Phys Med Rehabil; 1999; 78(5):500. PubMed ID: 10493461
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
    Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plastic changes in spinal synaptic transmission following botulinum toxin A in patients with post-stroke spasticity.
    Kerzoncuf M; Bensoussan L; Delarque A; Durand J; Viton JM; Rossi-Durand C
    J Rehabil Med; 2015 Nov; 47(10):910-6. PubMed ID: 26424152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: a clinical and electrophysiological study of the effects of block of nerve branches to the triceps surae muscle.
    Buffenoir K; Decq P; Lefaucheur JP
    Clin Neurophysiol; 2005 Jul; 116(7):1596-600. PubMed ID: 15905125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in upper limb spasticity: study of reciprocal inhibition between forearm muscles.
    Girlanda P; Quartarone A; Sinicropi S; Nicolosi C; Roberto ML; Picciolo G; Macaione V; Battaglia F; Ruggeri M; Messina C
    Neuroreport; 1997 Sep; 8(14):3039-44. PubMed ID: 9331911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of therapeutic ultrasound and transcutaneous electrical nerve stimulation compared with botulinum toxin type A in the treatment of spastic equinus in adults with chronic stroke: a pilot randomized controlled trial.
    Picelli A; Dambruoso F; Bronzato M; Barausse M; Gandolfi M; Smania N
    Top Stroke Rehabil; 2014; 21 Suppl 1():S8-16. PubMed ID: 24722047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the tendon reflex for assessing spasticity after botulinum toxin-a injection in children with cerebral palsy.
    Jang DH; Sung IY; Kang YJ
    J Child Neurol; 2013 Jan; 28(1):21-6. PubMed ID: 22832767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A.
    Geller AS
    Arch Phys Med Rehabil; 1997 Feb; 78(2):233-4. PubMed ID: 9041909
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin injection of the subscapularis muscle.
    Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
    J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A treatment of adult upper and lower limb spasticity.
    Hesse S; Brandi-Hesse B; Bardeleben A; Werner C; Funk M
    Drugs Aging; 2001; 18(4):255-62. PubMed ID: 11341473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection.
    Park ES; Park CI; Kim DY; Kim YR
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1592-6. PubMed ID: 12422331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke, spasticity, and botulinum toxin.
    Rowland LP
    N Engl J Med; 2002 Aug; 347(6):382-3. PubMed ID: 12167679
    [No Abstract]   [Full Text] [Related]  

  • 17. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional pharmacological treatments for spasticity. Part I: Local treatments.
    Gracies JM; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S61-91. PubMed ID: 9826983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.